A detailed history of Dn B Asset Management As transactions in Catalent, Inc. stock. As of the latest transaction made, Dn B Asset Management As holds 30,598 shares of CTLT stock, worth $1.83 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
30,598
Previous 27,711 10.42%
Holding current value
$1.83 Million
Previous $1.56 Million 9.97%
% of portfolio
0.01%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$53.58 - $57.02 $154,685 - $164,616
2,887 Added 10.42%
30,598 $1.72 Million
Q1 2024

Apr 12, 2024

SELL
$42.56 - $59.82 $106,357 - $149,490
-2,499 Reduced 8.27%
27,711 $1.56 Million
Q4 2023

Jan 04, 2024

SELL
$32.18 - $46.57 $3.06 Million - $4.43 Million
-95,110 Reduced 75.89%
30,210 $1.36 Million
Q3 2023

Oct 13, 2023

BUY
$44.2 - $50.2 $3.45 Million - $3.92 Million
78,047 Added 165.1%
125,320 $5.71 Million
Q2 2023

Jul 06, 2023

SELL
$31.86 - $67.26 $1.51 Million - $3.18 Million
-47,315 Reduced 50.02%
47,273 $2.05 Million
Q1 2023

Apr 20, 2023

BUY
$45.44 - $74.26 $3.08 Million - $5.03 Million
67,779 Added 252.82%
94,588 $6.22 Million
Q4 2022

Jan 12, 2023

SELL
$41.39 - $81.0 $15,728 - $30,780
-380 Reduced 1.4%
26,809 $1.21 Billion
Q3 2022

Oct 11, 2022

SELL
$72.36 - $113.1 $33,502 - $52,365
-463 Reduced 1.67%
27,189 $1.97 Million
Q1 2022

Apr 08, 2022

BUY
$94.19 - $124.49 $248,284 - $328,155
2,636 Added 10.54%
27,652 $3.07 Million
Q4 2021

Jan 12, 2022

BUY
$119.57 - $139.07 $249,781 - $290,517
2,089 Added 9.11%
25,016 $3.2 Million
Q3 2021

Oct 15, 2021

BUY
$109.17 - $142.35 $143,558 - $187,190
1,315 Added 6.08%
22,927 $3.05 Million
Q2 2021

Jul 06, 2021

BUY
$100.34 - $115.69 $46,858 - $54,027
467 Added 2.21%
21,612 $2.34 Billion
Q1 2021

Apr 15, 2021

BUY
$101.51 - $125.27 $170,739 - $210,704
1,682 Added 8.64%
21,145 $2.23 Million
Q4 2020

Jan 19, 2021

SELL
$85.88 - $105.36 $30,401 - $37,297
-354 Reduced 1.79%
19,463 $2.03 Million
Q3 2020

Oct 14, 2020

SELL
$72.74 - $92.5 $197,489 - $251,137
-2,715 Reduced 12.05%
19,817 $1.7 Million
Q2 2020

Jul 08, 2020

BUY
$48.02 - $79.04 $1.08 Million - $1.78 Million
22,532 New
22,532 $1.65 Billion

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Dn B Asset Management As Portfolio

Follow Dn B Asset Management As and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dn B Asset Management As, based on Form 13F filings with the SEC.

News

Stay updated on Dn B Asset Management As with notifications on news.